
Kobayashi Pharmaceutical Co., Ltd.
KBYPF
Updated: 22/09/2026, 22:57:46
Headquartered in Osaka, Japan, and established in 1886, Kobayashi Pharmaceutical Co., Ltd. is a global enterprise specializing in the development, manufacturing, and distribution of a wide array of consumer products. Its extensive offerings span key categories including healthcare, household necessities, skincare, and personal warming items. The company is recognized for a variety of popular brands such as Ammeltz (a topical pain reliever), Inochi no Haha (a women's health remedy), Sarasaty (lingerie soap), and Bluelet Decoral (a toilet cleaner and freshener). Their product lineup further includes Naishitol (a traditional Chinese medicine), Eaude Muge (an anti-acne medicated lotion), dental hygiene items like Itoyoji floss picks and BreathCare capsules, and eye care solutions such as Eyebon eye wash and Netsusama cooling gel sheets. Air fresheners like Sawaday and general deodorizing products, lens cleaners, and other oral hygiene items also form part of their portfolio. Beyond these, the company manufactures pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products. They also market nutritional supplements and skincare directly through online and telephone channels. Complementing its core business, Kobayashi Pharmaceutical is involved in various other activities, including transportation, real estate management, advertising planning and production, and asset management.
No summaries found.
- Share price
- $34.05
- Market cap
- $2.53B
- Exchange
- OTC
- Currency
- USD
- CEO
- Norikazu Toyoda
- Employees
- 3,731
- IPO date
- 14/09/2015
- Beta
- 0.254
- Last dividend
- $0.00
- Day range
- $34.05 – $34.05
- 52-week range
- $34.05 – $37.43
- 1-day performance
- 0.00%
- 1-year performance
- 0.00%
- Current drawdown (1Y)
- -9.03%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- JP3301100008
- Created
- 07/12/2025, 04:56:00
- Last update
- 22/09/2026, 22:57:46
Track Kobayashi Pharmaceutical Co., Ltd. with an AI analyst
See which prediction-market events move KBYPF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.